Abstract
This letter to the editor responds to recent comments by Strohbehn and Daugherty in Mistaking the Trees for the Forest.
MeSH terms
-
Decision Making
-
Humans
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
-
Patient Preference
-
Protein-Tyrosine Kinases / antagonists & inhibitors*